Guardant Health vs Grail
GH and GRAL side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GH and GRAL compare
Guardant Health is the larger company, worth 3.9 times as much as Grail ($20.4B against $5.2B).
Guardant Health grew revenue faster over the last twelve months (41.7% versus 17.5% for Grail).
Guardant Health keeps more of each dollar of sales as profit, with a net margin of −37.9% compared with −244% at Grail.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GH | GRAL |
|---|---|---|
| Size and price | ||
| Market cap | $20.4B | $5.2B |
| Share price | $151.70 | $115.89 |
| Change, 1 year | 55.0% | 36.7% |
| Change, 5 years | 55.5% | – |
| Beta (5Y) | 1.62 | 2.49 |
| Employees | 2,506 | 910 |
| StockData Score | ||
| Total score | 10 | 10 |
| Valuation score | 0 | 1 (better) |
| Growth score | 4 (better) | 2 |
| Performance score | 1 | 1 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 15.9× (better) | 31.1× |
| P/B | – | 2.1× |
| FCF yield | −1.1% (better) | −6.0% |
| Growth | ||
| Revenue growth (TTM) | 41.7% (better) | 17.5% |
| Revenue growth, 5Y average | 27.9% | – |
| Profitability | ||
| Gross margin | 65.2% | – |
| Operating margin | −39.4% (better) | −347% |
| Net margin | −37.9% (better) | −244% |
| FCF margin | −18.2% (better) | −187% |
| Return on equity | – | −17.3% |
| Return on invested capital | – | −27.1% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −96.6× | – |
| Current ratio | 3.60 | 8.93 (better) |
| Altman Z-score | 3.58 | 5.51 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Buyback yield | 0.00% | – |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 99.8% | 87.6% |
| Held by insiders | 1.8% | 11.0% |
| Insider net buying, 12 months | −$173M | −$38.0M (better) |
| Short interest, % of float | 7.2% | 20.1% |
Go deeper
- GH stock overview
- GH income statement
- GH valuation and score
- GRAL stock overview
- GRAL income statement
- GRAL valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.